ATE197461T1 - Herstellung von alpha-1-antichymotrypsin - Google Patents

Herstellung von alpha-1-antichymotrypsin

Info

Publication number
ATE197461T1
ATE197461T1 AT95111304T AT95111304T ATE197461T1 AT E197461 T1 ATE197461 T1 AT E197461T1 AT 95111304 T AT95111304 T AT 95111304T AT 95111304 T AT95111304 T AT 95111304T AT E197461 T1 ATE197461 T1 AT E197461T1
Authority
AT
Austria
Prior art keywords
antichymotrypsin
alpha
preparation
human alpha
act
Prior art date
Application number
AT95111304T
Other languages
English (en)
Inventor
Grace C Tsay
Neal K H Cheung
Jeffrey D Bettencourt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE197461T1 publication Critical patent/ATE197461T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95111304T 1994-07-29 1995-07-19 Herstellung von alpha-1-antichymotrypsin ATE197461T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/282,860 US5561108A (en) 1994-07-29 1994-07-29 Preparation of α1 -antichymotrypsin

Publications (1)

Publication Number Publication Date
ATE197461T1 true ATE197461T1 (de) 2000-11-11

Family

ID=23083438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95111304T ATE197461T1 (de) 1994-07-29 1995-07-19 Herstellung von alpha-1-antichymotrypsin

Country Status (12)

Country Link
US (1) US5561108A (de)
EP (1) EP0694562B1 (de)
JP (1) JP3693391B2 (de)
KR (1) KR100433115B1 (de)
CN (1) CN1175102C (de)
AT (1) ATE197461T1 (de)
CA (1) CA2154982C (de)
DE (1) DE69519338T2 (de)
DK (1) DK0694562T3 (de)
ES (1) ES2151570T3 (de)
GR (1) GR3035340T3 (de)
PT (1) PT694562E (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP751198A0 (en) * 1998-12-04 1999-01-07 Csl Limited Purification of A1-proteinase inhibitor
US20050265977A1 (en) * 1999-04-30 2005-12-01 Elliott Robert B Xenotransplant for CNS therapy
US20090047325A1 (en) * 1999-04-30 2009-02-19 Neurotrophincell Pty. Limited Xenotransplant for cns therapy
AU4440000A (en) * 1999-04-30 2000-11-17 Diatranz Limited Xenotransplant for cns therapy
ES2272482T3 (es) * 2000-01-20 2007-05-01 Diabcell Pty Limited Preparacion y xenotransplante de islotes porcinos.
ES2386505T3 (es) * 2000-10-17 2012-08-22 Diatranz Otsuka Limited Preparación y xenotrasplante de islotes de cerdo
NZ515310A (en) * 2001-11-07 2004-08-27 Diabcell Pty Ltd Methods of treatment and delivery modes
AU2003238760B2 (en) * 2003-06-24 2008-07-31 Diatranz Otsuka Limited Porcine islets cultured with porcine sertoli cells for xenotransplantation
NZ540597A (en) * 2005-06-08 2007-02-23 Neurotrophincell Pty Ltd A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells
CN103160486A (zh) * 2013-04-02 2013-06-19 黑龙江迪龙制药有限公司 一种猪凝血酶的制备方法
CN110964707A (zh) * 2019-12-31 2020-04-07 江西浩然生物制药有限公司 一种糜蛋白酶的提取纯化方法
CN112062833A (zh) * 2020-10-09 2020-12-11 国药集团武汉血液制品有限公司 一种从血浆组分ⅳ沉淀中提取人血白蛋白的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3271827D1 (en) * 1981-05-01 1986-07-31 Medical Research Inst Of San F Method for isolating alpha-1-antitrypsin
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production

Also Published As

Publication number Publication date
JPH08176197A (ja) 1996-07-09
PT694562E (pt) 2001-04-30
GR3035340T3 (en) 2001-05-31
AU700921B2 (en) 1999-01-14
EP0694562B1 (de) 2000-11-08
CA2154982A1 (en) 1996-01-30
AU2714395A (en) 1996-02-08
DE69519338T2 (de) 2001-05-31
DK0694562T3 (da) 2001-01-02
EP0694562A1 (de) 1996-01-31
ES2151570T3 (es) 2001-01-01
US5561108A (en) 1996-10-01
DE69519338D1 (de) 2000-12-14
CN1175102C (zh) 2004-11-10
KR100433115B1 (ko) 2004-08-30
CN1133885A (zh) 1996-10-23
KR960004367A (ko) 1996-02-23
JP3693391B2 (ja) 2005-09-07
CA2154982C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
DE69422997T2 (de) Blutsauerstoffsystem und herstellverfahren
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
ATE197461T1 (de) Herstellung von alpha-1-antichymotrypsin
TR28380A (tr) Urün imalinde dopun konsantrasyonunun denetimi.
MA23166A1 (fr) Procedes d'utilisation d'hesperetine pour le controle du sebum et le traitement de l'acne .
DE69202307D1 (de) Kryogenisches Rektifikationsverfahren zur Herstellung von gereinigtem Argon.
DE59406374D1 (de) Hydroxamsäuren und hydroxamsäureether sowie ihre verwendung als komplexbildner
ITMI932550A0 (it) Procedimento per la regolazione della macinatura come pure impianto per l'esecuzione del procedimento
IT8419730A0 (it) Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3.
DE69414525T2 (de) Differenzverstärkerstufe zur Verwendung in ECL-Bipolarstandardverfahren
DK0904070T3 (da) Anvendelse af buckminsterfulleren til behandling af neurotoksiske læsioner
IT1173473B (it) Procedimento per la preparazione di 1,8-diidrossi-10-acil-9-antroni,in particolare per l'uso nel trattamento di psoriasi
MA23388A1 (fr) Benzimidazole substitue , procedes de fabrication et d'application
ATE146526T1 (de) Neues thrombininhibitorisches protein aus zecken
KR970023499U (ko) 생물학적 순산소 개방형 폐수 처리장치
FR2633614B1 (fr) Procede de monohalogenation en (alpha) des groupements carbonyles des cetones
KR940022143U (ko) 공기 청정기의 전리부 구조
IT1274015B (it) Uso del ceruletide (takus) nel trattamento della psoriasi
IT1273868B (it) Perfezionamenti nelle cornici dei telai
ITBO940220U1 (it) Perfezionamenti nelle cornici dei telai
IT240452Y1 (it) Struttura di occhiali per ossigenoterapia ad elevata praticita' diimpiego
ITMI930768A0 (it) Dichiarazione ai sensi art. 4 del d.m. del 3 aprile 1981 (n. 2)
DE9306615U1 (de) Königsstuhl für Nachklärbecken in Kläranlagen
NO890088D0 (no) Fremgangsmaater for indusering av biologiske dekker i saar.
DE59405189D1 (de) Neues diphenylhexen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification